EHMSG 2020 Virtual Conference | Live Sessions

PROGRAMME

SATURDAY, SEPTEMBER 18, 2021

All times are Central European Summer Time (CEST)

08.00 – 08.15         Session 1 - Welcome and introduction

Mirjana Rajilic Stojanovic & Tomica Milosavljevic (Belgrade, Serbia)

 


08.15 – 08.35         Session 2 - Introductory lecture

 

A tribute to Samy Cadranel: H. pylori infection in Pediatrics beginning in Brussels  
Patrick Bontems (Brussels, Belgium)

 

08.35 - 09.35         Session 3 - Gastric carcinogenesis symposium

 

08.35 – 08.55

Quiescent stem cells: differentiated cells reprogram to fuel repair, metaplasia and neoplasia in the adult stomach

Jason C Mills (St Louis, MI, USA)

 

08.55 – 09.15    
The hippo pathway in gastric carcinogenesis
Christine Varon (Bordeaux, France)


09.15 – 09.35    
Extracellular vesicles from cancer-associated fibroblasts induce drug resistance
Takatsugu Ishimoto (Kumamoto, Japan)

 


09.35 - 09.45         Coffee Break

 


09.45 - 11.05         Session 4 - Gastric cancer symposium

09.45 – 10.05
Autoimmune gastritis and risk of GC
Christian Abnet (Rockville, MD, USA)


10.05 – 10.25    
How to follow patients with gastric premalignant lesions
Tamara Matysiak Budnik (Nantes, France)


10.25 – 10.45    
Mistakes in GC screening
Marcis Leja (Riga, Latvia)


10.45 – 11.05    
Elimination of GC related deaths in Japan
Mototsugu Kato (Hakadate, Japan)

 

11.05 - 12.05         Session 5 - RICHEN Symposium

 

 

12.05 – 13.00         Lunch Break

13.00 - 13.15         Session 6 - Awarding of the Marshall & Warren Medal

Dulciene Queiroz (Belo Horizonte, Brazil)

 

13.15 – 14.35         Session 7 - H. pylori treatment symposium


13.15 – 13.35    
Pathways of antimicrobial resistance through data sciences
Niyaz Ahmed (Hyderabad, India)


13.35 – 13.55    
The Korean registry on H. pylori eradication (Koreg): Transition in therapy
Joo Sung Kim (Seoul, Korea)


13.55 – 14.15    
What we have learned from the European H. pylori registry (HpEuReg)
Javier Gisbert (Madrid, Spain)


14.15 – 14.35    
Role of meta-analysis of H. pylori in the era of antimicrobial stewardship
David Graham (Houston, TX, USA)

 


14.35 – 14.45         5 Min Break

 


14.45 – 16.25         Session 8 - Microbiota Symposium

 

14.45 – 15.05    
Gastric microbiota changes during gastric carcinogenesis as a diagnostic biomarker
Jae Yong Park (Seoul, Korea)


15.05 – 15.25   
Correlation of microbiota composition and COVID immunity
Mirjana Rajilic Stojanovic (Belgrade, Serbia)


15.25 – 15.45    
Million microbiome from humans project, MMHP
Lars Engstrand (Stockholm, Sweden)


15.45 – 16.05    
How gut microbiota alters the brain
Gerard Clarke (Cork, Ireland)


16.05 – 16.25    
Microbiota in NAFLD/MAFLD
Herbert Tilg (Innsbruck, Austria)

 


16.25 – 16.40         Coffee Break

 


16.40 – 18.00         Session 9 - FMT symposium

16.40 – 17.00    
FMT in the COVID era
Josbert Keller (The Hague, The Netherlands)


17.00 – 17.20    
COVID risk during endoscopy and FMT
Gianluca Ianiro (Rome, Italy)


17.20 – 17.40
FMT for IBD
Sam Costello (Adelaide, Australia)


17.40 – 18.00
FMT to newborns
Katri Korpela (Helsinki, Finland)

 


18.00 – 18.30         Session 10 - Debate: Tools for modulating gut microbiota function, probiotics vs. prebiotics


18.00 – 18.15    
•    
Benefit of Prebiotics
Petia Petkova Datchary, Würzburg, Germany 
 

18.15 – 18.30
•    Benefit of Probiotics
Muriel Derrien, Palaiseau, France 


18.30 – 19.00         Session 11 - Closing Session


18.30 – 18.40   
Poster Awards

 

18.40 – 19.00
Presentation of the Workshop 2022 in Glasgow, United Kingdom
Georgina Hold (Sydney, Australia)

EHMSG 2021

European Helicobacter and Microbiota Study Group

© 2021 EHMSG

Core Agency

WMA GmbH

Alser Strasse 4, 1090 Vienna, Austria

  • zwitschern